Skip to main content
Premium Trial:

Request an Annual Quote

LabCorp Launches Clinical Sequencing Business, Enlighten Health Genomics

NEW YORK (GenomeWeb) – Laboratory Corporation of America today launched Enlighten Health Genomics to leverage the capabilities of next-generation sequencing technology in the clinical setting.

Part of LabCorp's Enlighten Health business — which provides services and tools to improve treatment decisions, lower costs, and improve patient outcomes — Enlighten Health Genomics will combine LabCorp's infrastructure and capabilities with the expertise of geneticists to offer diagnostic services, NGS analysis and interpretation, and genetic counseling.

Later this year, Enlighten Health Genomics will launch a whole-exome sequencing testing service called ExomeReveal, which will perform genome-wide interpretation of children with serious childhood genetic diseases, as well as diagnostic interpretation for patients regardless of age.

"Enlighten Health Genomics is an important part of LabCorp's strategy to capitalize on our unique assets, create new sources of revenue from our core capabilities, and meaningfully differentiate us from competitors," LabCorp Chairman and CEO David King said in a statement.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more